• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Combination Usage of Dexamethasone and Prednisolone Versus Prednisolone Monotherapy for Inflammation and Intraocular Pressure After Cataract Surgery.地塞米松与泼尼松龙联合使用对比泼尼松龙单药治疗白内障术后炎症和眼压的效果
Cureus. 2025 Jan 2;17(1):e76790. doi: 10.7759/cureus.76790. eCollection 2025 Jan.
2
Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysis.9%地塞米松眼内混悬液对常规白内障手术后眼压的影响:事后分析
J Cataract Refract Surg. 2021 Jan 1;47(1):53-64. doi: 10.1097/j.jcrs.0000000000000363.
3
Safety and efficacy of travoprost intracameral implant administered in combination with cataract surgery.曲伏前列素前房内植入联合白内障手术的安全性和有效性
Ther Adv Ophthalmol. 2025 Feb 14;17:25158414241310275. doi: 10.1177/25158414241310275. eCollection 2025 Jan-Dec.
4
Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide.局部地塞米松滴眼液在单纯白内障手术后预防眼内炎症和囊样黄斑水肿的疗效,无论是否在围手术期单次注射曲安奈德前Tenon 囊下注射。
Cutan Ocul Toxicol. 2022 Dec;41(4):310-317. doi: 10.1080/15569527.2022.2136193. Epub 2022 Oct 29.
5
Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma.青光眼术后应用 iStent 和 Hydrus 行巩膜睫状体腔内注射地塞米松或局部应用泼尼松龙。
J Glaucoma. 2022 Aug 1;31(8):694-699. doi: 10.1097/IJG.0000000000002037. Epub 2022 Apr 14.
6
Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone.先天性白内障手术结果:术中前房内曲安奈德注射与术后口服泼尼松龙的比较。
J Cataract Refract Surg. 2014 Apr;40(4):601-8. doi: 10.1016/j.jcrs.2013.09.011. Epub 2014 Feb 13.
7
Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye.用于白内障手术的Surodex类固醇药物递送系统的随机临床试验:在眼中将两个Surodex分别置于前部和后部的比较。
Ophthalmology. 2001 Dec;108(12):2172-81. doi: 10.1016/s0161-6420(01)00839-9.
8
Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial.泼尼松龙和酮咯酸与酮咯酸单药治疗或术尔泰预防白内障手术中黄斑增厚的比较:一项随机临床试验。
JAMA Ophthalmol. 2021 Oct 1;139(10):1062-1070. doi: 10.1001/jamaophthalmol.2021.2976.
9
Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension.醋酸泼尼松龙 1.0%与二氟泼尼龙眼用乳剂 0.05%在白内障手术后的比较:术后皮质类固醇诱导性高眼压的发生率。
J Cataract Refract Surg. 2017 Feb;43(2):223-227. doi: 10.1016/j.jcrs.2017.02.002.
10
Difluprednate versus Prednisolone Acetate after Cataract Surgery: a Systematic Review and Meta-Analysis.白内障手术后二氟泼尼酯与醋酸泼尼松龙的疗效比较:系统评价和荟萃分析。
BMJ Open. 2019 Nov 2;9(11):e026752. doi: 10.1136/bmjopen-2018-026752.

本文引用的文献

1
Dexamethasone Intracanalicular Insert versus Standard Topical Steroids for the Prophylaxis of Inflammation after Cataract Surgery.地塞米松眼内植入物与标准局部用类固醇预防白内障手术后炎症的比较
Am J Ophthalmol. 2024 Dec;268:174-180. doi: 10.1016/j.ajo.2024.07.030. Epub 2024 Jul 31.
2
Extended depth of focus IOL in eyes with different axial myopia and targeted refraction.不同轴向近视眼的扩展景深人工晶状体与目标屈光。
BMC Ophthalmol. 2024 Apr 22;24(1):183. doi: 10.1186/s12886-024-03442-5.
3
Innate immune responsive inflammation in development of progressive myopia.先天免疫反应性炎症在近视进展中的作用。
Eye (Lond). 2024 Jun;38(8):1542-1548. doi: 10.1038/s41433-024-02947-z. Epub 2024 Jan 29.
4
Visual outcome and postoperative complications of cataract surgery in patients with ocular surface disorders.眼表疾病患者白内障手术的视觉预后及术后并发症
J Cataract Refract Surg. 2024 May 1;50(5):474-480. doi: 10.1097/j.jcrs.0000000000001396.
5
Corneal Edema after Cataract Surgery.白内障手术后的角膜水肿
J Clin Med. 2023 Oct 25;12(21):6751. doi: 10.3390/jcm12216751.
6
The relationship between patient satisfaction and visual and optical outcome after bilateral implantation of an extended depth of focus multifocal intraocular lens.双眼植入扩展景深多焦点人工晶状体后患者满意度与视觉及光学效果之间的关系
Adv Ophthalmol Pract Res. 2022 Mar 11;2(1):100043. doi: 10.1016/j.aopr.2022.100043. eCollection 2022 May-Jun.
7
A Randomized, Prospective, Observer-Masked Study Comparing Dropless Treatment Regimen Using Intracanalicular Dexamethasone Insert, Intracameral Ketorolac, and Intracameral Moxifloxacin versus Conventional Topical Therapy to Control Postoperative Pain and Inflammation in Cataract Surgery.一项随机、前瞻性、观察者盲法研究,比较使用泪小管内插入地塞米松、前房内注射酮咯酸和前房内注射莫西沙星的无滴剂治疗方案与传统局部治疗方案对白内障手术术后疼痛和炎症的控制效果。
Clin Ophthalmol. 2023 Aug 15;17:2349-2356. doi: 10.2147/OPTH.S422502. eCollection 2023.
8
Endophthalmitis following cataract surgery: visual outcomes, microbial spectrum and complications.白内障手术后的眼内炎:视力预后、微生物谱及并发症
Curr Opin Ophthalmol. 2023 May 1;34(3):237-242. doi: 10.1097/ICU.0000000000000951. Epub 2023 Mar 20.
9
Cataract Surgery-Indications, Techniques, and Intraocular Lens Selection.白内障手术——适应证、技术和人工晶状体选择。
Dtsch Arztebl Int. 2023 May 30;120(21):377-386. doi: 10.3238/arztebl.m2023.0028.
10
Five-year incidence of primary glaucoma and related risk factors - The Handan eye study.原发性青光眼的 5 年发病率及相关危险因素 - 邯郸眼病研究。
Acta Ophthalmol. 2023 Feb;101(1):e50-e60. doi: 10.1111/aos.15216. Epub 2022 Jul 13.

地塞米松与泼尼松龙联合使用对比泼尼松龙单药治疗白内障术后炎症和眼压的效果

The Combination Usage of Dexamethasone and Prednisolone Versus Prednisolone Monotherapy for Inflammation and Intraocular Pressure After Cataract Surgery.

作者信息

Lee Chia-Yi, Yang Shun-Fa, Huang Chin-Te, Huang Jing-Yang, Chang Chao Kai

机构信息

Institute of Medicine, Chung Shan Medical University, Taichung, TWN.

Department of Medical Research, Chung Shan Medical University Hospital, Taichung, TWN.

出版信息

Cureus. 2025 Jan 2;17(1):e76790. doi: 10.7759/cureus.76790. eCollection 2025 Jan.

DOI:10.7759/cureus.76790
PMID:39897294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11787048/
Abstract

Purpose The purpose of this study is to survey the anti-inflammatory effect of combined preoperative dexamethasone and postoperative prednisolone therapy and postoperative prednisolone therapy for cataract surgery. The intraocular pressure (IOP) change between groups was also examined. Methods A retrospective cohort study was practiced, and individuals who received cataract surgery were enrolled and categorized according to the anti-inflammation therapy. A total of 62 and 108 eyes were included in the combined and single groups, respectively. The primary outcomes were ocular hypertension and anterior chamber (AC) inflammation. The independent t-test and generalized linear model were used for the statistical analysis. Results There were 12 and 16 episodes of ocular hypertension in the combined and single groups, and the incidence of ocular hypertension was similar between groups (P = 0.203). In addition, there were four and seven AC inflammation events in the combined and single groups, and the incidences of AC inflammation were similar between groups (P = 0.335). Old age was correlated to a higher risk of developing ocular hypertension in the combined and single groups (both P < 0.05). Besides, higher myopia is related to higher ocular hypertension risk in the combined group (P = 0.038). Preoperative dry eye disease (DED) was associated with higher AC inflammation risk in the combined and single groups (both P < 0.05). Also, the high myopia was related to higher AC inflammation risk in the two groups (both P < 0.05). Conclusion The combination therapy of dexamethasone and prednisolone showed similar anti-inflammatory effects. The IOP changes between groups were similar.

摘要

目的 本研究旨在调查白内障手术前联合使用地塞米松和术后使用泼尼松龙治疗以及术后单独使用泼尼松龙治疗的抗炎效果。同时也检测了两组之间的眼压(IOP)变化。方法 进行了一项回顾性队列研究,纳入接受白内障手术的患者,并根据抗炎治疗方法进行分类。联合治疗组和单一治疗组分别纳入了62只眼和108只眼。主要结局指标为高眼压和前房(AC)炎症。采用独立t检验和广义线性模型进行统计分析。结果 联合治疗组和单一治疗组分别有12例和16例高眼压发作,两组高眼压发生率相似(P = 0.203)。此外,联合治疗组和单一治疗组分别有4例和7例AC炎症事件,两组AC炎症发生率相似(P = 0.335)。在联合治疗组和单一治疗组中,老年与发生高眼压的风险较高相关(均P < 0.05)。此外,在联合治疗组中,高度近视与高眼压风险较高相关(P = 0.038)。术前干眼症(DED)与联合治疗组和单一治疗组中较高的AC炎症风险相关(均P < 0.05)。而且,高度近视与两组中较高的AC炎症风险相关(均P < 0.05)。结论 地塞米松和泼尼松龙的联合治疗显示出相似的抗炎效果。两组之间的眼压变化相似。